A leap forward in Genetic Disorder Treatments: Aptadir Therapeutics’ groundbreaking RNA Inhibitors

News

Milan, Italy, 24 September 2024: Aptadir Therapeutics is pioneering a revolutionary approach in the realm of biotechnology with its innovative RNA inhibitor-based therapies. The biotech startup has recently announced a significant breakthrough that could reshape treatment strategies for intractable cancers and genetic conditions. Breaking new ground with RNA Inhibitors   Aptadir’s research centers on RNA…

EVOTEC, CDP VENTURE CAPITAL AND ANGELINI VENTURES LAUNCH TRANSLATIONAL PARTNERSHIP “EXTEND” WITH LEADING ITALIAN ACADEMIC INSTITUTIONS

News

Hamburg, Germany, 28 October 2022: EXTEND AIMS TO DEVELOP DRUG DISCOVERY PARTNERSHIPS WITH LEADING ACADEMIC INSTITUTIONS FROM ITALY TO ACCELERATE THEIR PROMISING THERAPEUTICS FOR COMMERCIALISATION Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the launch of “Extend”, a translational BRIDGE partnership in cooperation with CDP Venture Capital Sgr, a strategic…

Biotechnology Startups: CEINGE Becomes Scientific Promoter of EXTEND for Southern Italy

News

Sviluppo di startup nell’ambito delle scienze della vita, in particolare nel settore delle biotecnologie e del drug discovery: il CEINGE-Biotecnologie Avanzate Franco Salvatore di Napoli, grazie un accordo di collaborazione siglato con EXTEND, il Polo Nazionale di Trasferimento Tecnologico di CDP Venture Capital per il settore biofarmaceutico, si candida a diventare l’hub del Sud Italia…